Relay Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Hello, again, everyone. My name is Etzer Darout, one of the senior biotech analysts at Barclays. It's my pleasure to have our next fireside chat with Relay Therapeutics.
With us this morning, we have Sanjiv Patel, CEO of Relay; and Peter Rammer, Chief Corporate and Development Officer. Thank you so much for joining us this morning.
Maybe Sanjiv, just to get us started, maybe a brief overview of Relay Therapeutics for those maybe less familiar with the story.
Yes. Well, first of all, thank you, sir, for the invite thing to Barclays, and it's always a pleasure to be here. So the company has been around now close to 10 years or a company that's focused on trying to drug precision medicine targets.
And we have a very exciting year ahead. It's been set up because over the last couple of years, like every company in our industry, we've weathered the very tough environment biotechs have been through.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
